Home
>
National Drug Code (NDC)
>
oxaprozin
oxaprozin - 60505-0176-1 - (oxaprozin)
Drug Information of oxaprozin
| Product NDC: | 60505-0176 |
| Proprietary Name: | oxaprozin |
| Non Proprietary Name: | oxaprozin |
| Active Ingredient(s): | 600 mg/1 & nbsp; oxaprozin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of oxaprozin
| Product NDC: | 60505-0176 |
| Labeler Name: | Apotex Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075987 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040903 |
Package Information of oxaprozin
| Package NDC: | 60505-0176-1 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0176-1) |
NDC Information of oxaprozin
| NDC Code | 60505-0176-1 |
| Proprietary Name | oxaprozin |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (60505-0176-1) |
| Product NDC | 60505-0176 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | oxaprozin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20040903 |
| Marketing Category Name | ANDA |
| Labeler Name | Apotex Corp. |
| Substance Name | OXAPROZIN |
| Strength Number | 600 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
